GNPX

insider transactions

Genprex, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Other·F
Feb 27, 26

Berger Mark Stanley

Chief Medical Officer

$14.3K

7.2K sh · $2.00

Own -25%
Other·F
Feb 27, 26

Confer Ryan M. KEY

President, CEO and CFO

$18.7K

9.3K sh · $2.00

Own -20%
Grant·A
Dec 22, 25

Moreno Toscano Jose Antonio

Director

$0

9.0K sh

Own +5732%
Grant·A
Dec 22, 25

LONGNECKER BRENT M

Director

$0

9.0K sh

Own +5455%
Grant·A
Dec 22, 25

Confer Ryan M. KEY

President, CEO and CFO

$0

45.0K sh

Own +6808%
Grant·A
Dec 22, 25

Berger Mark Stanley

Chief Medical Officer

$0

28.5K sh

Own +7917%
Grant·A
Dec 22, 25

Wilson William R Jr.

Director

$0

9.0K sh

Own +5732%
Other·F
Jun 30, 25

Confer Ryan M. KEY

President, CEO and CFO

$1.3K

5.8K sh · $0.23

Own -15%
Other·F
Jun 30, 25

Berger Mark Stanley

Chief Medical Officer

$1.0K

4.5K sh · $0.23

Own -20%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Feb 27, 2026	Berger Mark Stanley	Chief Medical Officer	Other F	7.2K	-25%	$2.00	$14.3K
Feb 27, 2026	Confer Ryan M. KEY	President, CEO and CFO	Other F	9.3K	-20%	$2.00	$18.7K
Dec 22, 2025	Moreno Toscano Jose Antonio	Director	Grant A	9.0K	+5732%	—	$0
Dec 22, 2025	LONGNECKER BRENT M	Director	Grant A	9.0K	+5455%	—	$0
Dec 22, 2025	Confer Ryan M. KEY	President, CEO and CFO	Grant A	45.0K	+6808%	—	$0
Dec 22, 2025	Berger Mark Stanley	Chief Medical Officer	Grant A	28.5K	+7917%	—	$0
Dec 22, 2025	Wilson William R Jr.	Director	Grant A	9.0K	+5732%	—	$0
Jun 30, 2025	Confer Ryan M. KEY	President, CEO and CFO	Other F	5.8K	-15%	$0.23	$1.3K
Jun 30, 2025	Berger Mark Stanley	Chief Medical Officer	Other F	4.5K	-20%	$0.23	$1.0K

About GNPX insider trading

This page tracks insider transactions for Genprex, Inc. (GNPX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.